These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 15787672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Diabetic neuropathy is associated with activation of the TNF-alpha system in subjects with type 1 diabetes mellitus.
    González-Clemente JM, Mauricio D, Richart C, Broch M, Caixàs A, Megia A, Giménez-Palop O, Simón I, Martínez-Riquelme A, Giménez-Pérez G, Vendrell J.
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):525-9. PubMed ID: 16268804
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration.
    Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA.
    Diabetologia; 2001 Jun; 44(6):729-37. PubMed ID: 11440366
    [Abstract] [Full Text] [Related]

  • 11. Rapid restoration of normoglycaemia using intravenous insulin boluses.
    Dunnett JM, Steemson J, Sear JW, Turner RC, Holman RR.
    Diabetes Res; 1990 Dec; 15(4):151-5. PubMed ID: 2132403
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus.
    Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J.
    J Clin Invest; 1998 Aug 01; 102(3):619-24. PubMed ID: 9691098
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduced serum homocysteine levels in type 2 diabetes.
    Mazza A, Bossone E, Mazza F, Distante A.
    Nutr Metab Cardiovasc Dis; 2005 Apr 01; 15(2):118-24. PubMed ID: 15871860
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
    Toft I, Jenssen T.
    Scand J Clin Lab Invest; 2005 Apr 01; 65(4):307-20. PubMed ID: 16076686
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
    Triplitt C, Glass L, Miyazaki Y, Wajcberg E, Gastaldelli A, De Filippis E, Cersosimo E, DeFronzo RA.
    Diabetes Care; 2006 Nov 01; 29(11):2371-7. PubMed ID: 17065670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.